Related Experiment Videos
Developments in breast cancer therapy
1University of North Carolina School of Pharmacy, Chapel Hill, USA.
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)
|September 26, 2002
Summary
Breast cancer affects 1 in 8 women, with survival depending heavily on early detection. Treatment advances, including surgery and medications like tamoxifen and aromatase inhibitors, improve survival rates, especially in earlier stages.
Area of Science:
- Oncology
- Medical treatment of breast cancer
Background:
- Lifetime breast cancer risk is 1 in 8 for women.
- Incidence increases after age 40.
- Early-stage detection (Stages I and II) is crucial for curability.
Purpose of the Study:
- To summarize current breast cancer treatment standards and outcomes.
- To highlight the impact of advancements in therapy.
Main Methods:
- Review of standard treatments for primary local therapy.
- Discussion of adjuvant therapies for recurrence prevention.
- Overview of treatments for metastatic disease.
Main Results:
- Breast-conserving surgery is the standard for primary local therapy.
- Tamoxifen (20 mg/day for 5 years) is recommended for recurrence prevention.
- Aromatase inhibitors are first-line for metastatic disease.
- Trastuzumab has improved 5-year survival rates.
Conclusions:
- Early detection and treatment significantly improve breast cancer outcomes.
- Modern therapies, including targeted agents, enhance survival in advanced disease.